[ Allurion Technologies raises $27M in Series C funding ]

Allurion Technologies has raised $27 million in Series C funding.

Founded in 2009, Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.

The funding will support the company’s FDA pivotal study, which will start next year; build the sales and marketing team to increase sales outside the U.S. and improve manufacturing.

Funding  Series C
Founded  2009
Country  USA
City  Wellesley, Massachusetts
Founder / CEO  Jonathan Wecker
Deal Size  $27M
Investors  Romulus Capital
 IDO Investments
Previous Investors  Romulus Capital